Hernia surgery drug trial halted early – what it means for patients
NCT ID NCT04491526
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether tamsulosin, a drug used for prostate symptoms, could prevent men from having trouble urinating after hernia repair. The trial planned to include 312 men aged 60 and older, but it was stopped early. Because it was terminated, we cannot draw firm conclusions about whether the drug works for this purpose.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- tamsulosin
- What this could lead to
- If effective, tamsulosin could reduce the need for catheterization after hernia surgery, making recovery easier for men.
- What could go wrong
- The trial was terminated early, so we don't have clear evidence. Tamsulosin may cause dizziness or low blood pressure in some men.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INGUINAL HERNIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kantonsspital Baden
Baden, Canton of Aargau, 5404, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which robot is faster for hernia surgery? a Head-to-Head test
- Robots vs. scalpels: can High-Tech hernia repair get you home sooner?
- New catheter design aims to make Self-Catheterization easier and more comfortable
- One cut vs three: could a single incision make hernia surgery less painful?
- Can a precise prostate surgery predict better outcomes? a new study aims to find out.
- Could a muscle relaxant cut opioid use after hernia surgery?